1、 Rendhan A,Smith U,Kirkman MS.Linking diabetes and cancer:a consensus on complexity[J]. Lancet,2110(375):2201-2202. Rendhan A,Smith U,Kirkman MS.Linking diabetes and cancer:a consensus on complexity[J]. Lancet,2110(375):2201-2202.
2、 Chang CK,Ulrich CM.Hyperinsulinaemia and hyperglycaemia:possible risk factors of colorectal cancer among diabetic patients [J].Diabetologia,2003,46(5):595-607. Chang CK,Ulrich CM.Hyperinsulinaemia and hyperglycaemia:possible risk factors of colorectal cancer among diabetic patients [J].Diabetologia,2003,46(5):595-607.
3、 韦华,王民登.糖尿病与肿瘤关系研究现状[J].中外医学研究,2011,9(22):155-157. 韦华,王民登.糖尿病与肿瘤关系研究现状[J].中外医学研究,2011,9(22):155-157.
4、 陈灏珠.实用内科学[M]. 12 版.北京:人民卫生出版社,2005:1022. 陈灏珠.实用内科学[M]. 12 版.北京:人民卫生出版社,2005:1022.
5、 Gul K,Nas S,Ozdemir D,et al. CA199 level in patients with tupe 2 diabetes mellitus and its relation to the metabolic control and microvascular complications[J]. Am J Med Sci,2011,341(1):28-32. Gul K,Nas S,Ozdemir D,et al. CA199 level in patients with tupe 2 diabetes mellitus and its relation to the metabolic control and microvascular complications[J]. Am J Med Sci,2011,341(1):28-32.
6、 赵琪,黄学文.糖尿病患者血清中CA19-9水平与唾液酸及Lewis血型的关系[J].临床检验杂志,2008,26(2):137-139. 赵琪,黄学文.糖尿病患者血清中CA19-9水平与唾液酸及Lewis血型的关系[J].临床检验杂志,2008,26(2):137-139.
7、 彭敏,黄平.血糖波动与CA19-9水平变化的相关性研究进展[J].浙江临床医学,2009,11(6),644-646. 彭敏,黄平.血糖波动与CA19-9水平变化的相关性研究进展[J].浙江临床医学,2009,11(6),644-646.
8、 于永浩,包玉倩,张磊,等.住院糖尿病患者CA199水平与血糖控制程度的关系[J].中华医学杂志, 2010,90(6):394-395. 于永浩,包玉倩,张磊,等.住院糖尿病患者CA199水平与血糖控制程度的关系[J].中华医学杂志, 2010,90(6):394-395.
9、 何双涛,刘军,周连华.2型糖尿病患者血糖、胰岛素抵抗和B细胞功能对CA199水平的影响.中国糖尿病杂志,2012,20(7): 493-495. 何双涛,刘军,周连华.2型糖尿病患者血糖、胰岛素抵抗和B细胞功能对CA199水平的影响.中国糖尿病杂志,2012,20(7): 493-495.
10、 申小英,马丽娜,俞孝芳,等.2型糖尿病患者血清CAl99水平的观察分析[J]. 现代实用医学,2009,12(12):1291-1334. 申小英,马丽娜,俞孝芳,等.2型糖尿病患者血清CAl99水平的观察分析[J]. 现代实用医学,2009,12(12):1291-1334.
11、 许成新,成世勇,沈树标,等. 996例糖类抗原CAl99阳性者临床检验分析[J].中国现代临床医学杂志,2008,7(2):28-29. 许成新,成世勇,沈树标,等. 996例糖类抗原CAl99阳性者临床检验分析[J].中国现代临床医学杂志,2008,7(2):28-29.
12、 Benhamou PY,Vuilles JP, Halimi S, et al. Influence of metabolic disturbances of diabetes mellitus onserum CA199 tumor marker[J]. Diabete Metab,1991,17(1):39-43. Benhamou PY,Vuilles JP, Halimi S, et al. Influence of metabolic disturbances of diabetes mellitus onserum CA199 tumor marker[J]. Diabete Metab,1991,17(1):39-43.
13、 徐美华,张桂英,张鹏.CAl25在结核性腹膜炎患者中的临床意义[J]. 世界华人消化杂志,2005,13(9):1156-1157. 徐美华,张桂英,张鹏.CAl25在结核性腹膜炎患者中的临床意义[J]. 世界华人消化杂志,2005,13(9):1156-1157.
14、 Morris-Stiff G,Teli M,Jardine N,et al. CAl99 antigen levels can distinguish between benignand malignant pancreaticobiliary disease[J]. Hepatobiliary Pancreat Dis Int,2009(8):620-626. Morris-Stiff G,Teli M,Jardine N,et al. CAl99 antigen levels can distinguish between benignand malignant pancreaticobiliary disease[J]. Hepatobiliary Pancreat Dis Int,2009(8):620-626.
15、 曹晶晶,彭俊华,殷瑞鹏,等.影响糖化血红蛋白HbA1c检测结果的因素分析[J].现代检验医学杂志,2012.27(5):75-76. 曹晶晶,彭俊华,殷瑞鹏,等.影响糖化血红蛋白HbA1c检测结果的因素分析[J].现代检验医学杂志,2012.27(5):75-76.
16、 Ben Q,Cai Q,Li Z, et al. The relationship between new-onset diabetes mellitus and pancreatic cancer risk, a case-control study[J].Eur J Cancer,2011,47 (2),248-254. Ben Q,Cai Q,Li Z, et al. The relationship between new-onset diabetes mellitus and pancreatic cancer risk, a case-control study[J].Eur J Cancer,2011,47 (2),248-254.
17、 Uygur-Bayramicli O, Dabakr, Orbaye, E, et al. Type 2 diabetes mellitus and CA199 levels[J].World J Gastroenterol,2007,13(40):5357-5359. Uygur-Bayramicli O, Dabakr, Orbaye, E, et al. Type 2 diabetes mellitus and CA199 levels[J].World J Gastroenterol,2007,13(40):5357-5359.
